Third-Generation ALK-Inhibitor Demonstrates Efficacy in ALK Positive NSCLC
Designed to target CNS lesions, lorlartinib finds its mark In a phase III trial for patients with...
Breaking Oncology / Hematology
Vitamin D Shows Reduction of Metastatic/Fatal Cancers in Patients with Normal BMI
Efficacy was not seen in overweight individuals or those with obesity High-dose vitamin D...
Breast Density Part of Rubric for Predicting Lymphedema Risk after Breast Ca Tx
A clinical tool with 5 prognostic variables, including mammographic breast density, predicted risk...
